Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Stephens on Wednesday raised its price target for WSFS Financial to $71 from $66 and kept an Overweight rating after the bank reported quarterly results that outperformed expectations across several operating metrics, including core pre-provision net revenue, loan growth, net interest margin, and quarterly earnings and revenue.
William Blair reiterated its Market Perform rating on Korro Bio Inc. (KRRO) after the company presented preclinical results for its lead program, KRRO-121. The firm called the data and development plan an "incremental positive" as Korro works to rebound following a prior program failure. While analysts acknowledged therapeutic potential and a favor…
Raymond James has reaffirmed a Market Perform rating on Korro Bio Inc. (NASDAQ:KRRO). The research note cited preclinical evidence for the company’s lead program, KRRO-121, alongside patient anecdotes highlighting the burden of urea cycle disorders (UCD). Korro’s shares trade at $10.74 with a market capitalization of $101.14 million and show mixed …
Mizuho upgraded Applied Materials to Outperform from Neutral and raised its price target to $370 from $275, citing a sharp rebound in wafer fab equipment (WFE) spending and stronger demand from foundry and logic customers. The firm now projects WFE growth of 13% year-over-year in 2026 and 12% in 2027, and points to higher TSMC capex and improving I…
CalciMedica Inc. (NASDAQ:CALC) saw its stock fall roughly 80% on Wednesday after an Independent Data Monitoring Committee recommended stopping the Phase 2 KOURAGE trial for acute kidney injury due to safety concerns. The company said no deaths were attributed to the study drug and no serious adverse events required expedited FDA reporting. CalciMed…
Textron posted higher fourth-quarter revenue and adjusted earnings, driven by recovering aircraft production and robust demand for aftermarket parts and services in its aviation business. The company’s 2026 profit guidance, however, came in below Wall Street expectations, prompting a pre-market share decline.
MSCI reported stronger adjusted profit for the quarter ended December 31, driven by increased client spending on its index products and analytics services. Asset-based fees rose, lifting overall revenue, while operating costs grew more modestly as the company invested in staff and technology. Management highlighted continued multi-year growth in ad…
Mastercard (MA) has pulled back to roughly $522 after a sharp slide from the $600s, leaving the stock oversold (RSI ~29.9) and well below its 20- and 50-day averages. With earnings due 01/29/2026 and consumer spending described as holding firm in recent coverage, MA sets up as a tactical long: defined risk below recent lows and upside toward the fi…
Wix.com Ltd. shares rose sharply after the company’s board approved a $2 billion share repurchase program spanning fiscal years 2026-2027. The authorization permits purchases of ordinary shares and convertible notes via open market and private transactions, to be funded by cash on hand, operating cash flow, or potentially new capital. The program i…
Ryanair's chief executive says the carrier could provide free Wi-Fi on every aircraft within three to five years as connectivity technology evolves to remove current fuel costs associated with rooftop antennas. The CEO also reiterated that governments, not airlines, should fund measures to prevent drone incursions that have disrupted European fligh…
Mobico Group reported that a subsidiary is in advanced negotiations with five public transport authorities in Germany to adjust rail service contracts across North Rhine-Westphalia and nearby regions. The announcement coincided with a more than 13% rise in the group's shares as markets reacted to the prospect of contract realignment intended to cre…
Goldman Sachs has reaffirmed a Neutral rating and a $223.00 price target on AbbVie as the company prepares to issue 2026 guidance alongside fourth-quarter 2025 results on February 4. The bank highlights investor debate over competitive pressures for Skyrizi and Rinvoq and notes management will stop updating mid-term guidance for those products. Gol…
JPMorgan raised its price target on Corning to $115 from $100 and kept an Overweight rating following the announcement of a multiyear supply agreement with Meta worth up to $6 billion. The pact is expected to support Meta’s data center expansion and spur additional investment in Corning’s North Carolina manufacturing footprint, including a new opti…
JPMorgan reaffirmed an Overweight rating on ASML and set a $1,518 price target, citing a substantial beat in fourth-quarter 2025 orders. The company reported record revenue and robust bookings that suggest stronger results ahead, while select valuation metrics indicate the stock may be rich relative to fair value.
Residents of Silwan in East Jerusalem report receiving eviction orders that favor Ateret Cohanim, a settler organization that has acquired dozens of properties in the district. Dozens of families have been told to leave under a Supreme Court order, with deadlines tied to the end of Ramadan - mid-March - while tensions over settlement activity and a…
Birkenstock has set a target of generating 1 billion euros in incremental revenue across the next three years, aiming for annual top-line growth of 13%-15% at constant currencies. The company expects double-digit expansion in the Americas and EMEA, a doubling of its Asia-Pacific business, and adjusted EPS to grow about 200 basis points faster than …
U.S. stock futures inched higher ahead of the Federal Reserve rate decision, with several corporate earnings reports and operational updates steering premarket activity. Telecom, chipmakers and data-storage names led gains, while a handful of industrial and consumer-facing firms fell despite some beating quarterly estimates.
Morgan Stanley expects most European aerospace and defence firms to meet or beat forecasts for fiscal 2025 and has revised its sector preferences. The bank highlights Rolls-Royce as the leading aerospace pick and Rheinmetall in defence, while signalling that management commentary around 2026 will carry greater weight than FY25 headlines.
Saudi Arabia's stock market ended the trading day higher, with the Tadawul All Share index climbing 0.67% to a one-month high. Gains were concentrated in the Insurance, Petrochemicals and Industrial Investment sectors, while market breadth was mixed as more stocks fell than rose. Commodity prices for crude, Brent and gold moved higher, and key curr…
Travis Kelce will take a stake of under 5% in Sleep Number and serve as a national advertising spokesman for the mattress maker over the next three years. The deal includes a combination of purchased shares and restricted stock that vests over three years. The move comes as Sleep Number pursues a turnaround under new CEO Linda Findley amid declinin…
Corning projected first-quarter core sales above analysts' estimates, driven by steady demand for its fiber-optic products, which account for nearly 40% of company revenue. The company highlighted ongoing investment in optical communications and announced a potential up to $6 billion multi-year supply agreement with Meta Platforms for AI-focused da…
H.C. Wainwright has reaffirmed a Buy rating and a $10.00 price target on Cardiff Oncology (CRDF) after the company disclosed updated clinical results from its CRDF-004 trial. The price target implies notable upside versus the current roughly $2 share price. Trial findings and upcoming regulatory and clinical milestones are informing near-term inves…
BMO Capital raised its price objective on Stride Inc. (NYSE: LRN) to $94 from $75 while retaining a Market Perform rating, citing fiscal second-quarter 2026 results that beat expectations largely due to a one-time gain. Management reaffirmed full-year revenue guidance and raised adjusted operating income expectations, even as core General Education…
H.C. Wainwright retained its Buy rating on Kazia Therapeutics and affirmed an $18.00 price target after the company released updated Phase 1b data for paxalisib in combination with pembrolizumab and chemotherapy in late-stage metastatic triple-negative breast cancer (TNBC). The small-cap biotech, trading at $7.15 with a market capitalization of $77…
President Donald Trump issued a public ultimatum urging Iran to negotiate a nuclear deal or face a more severe U.S. military response, writing that time is running out and calling for an agreement with "NO NUCLEAR WEAPONS." He said the previous warning led to a strike and warned that the next attack would be "far worse," while also asserting that a…
